CALCiViS News

CALCiViS to present at the 5th Annual MedTech & Digital Health Forum in Basel, Switzerland

Edinburgh, 22 September 2017 – CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that its Chief Executive Officer (CEO) Adam Christie will present at the Sachs 5th Annual MedTech & Digital Health Forum on 25 September 2017 at 10:45am CET...

CALCiViS presents imaging system to Parliament

July 12th 2017. CALCiViS imaging system developer and Chief Technical Officer, Bruce Vernon, presents the CALCiViS imaging system to an All Parliamentary Group for Dental innovation as part of the British Dental Industry Associations  "innovation in Dentistry" group. Link to images The session, jointly organised by the British Dental Industry Association...

CALCiViS presents new clinical evidence to International Research Association

July 5th to 8th 2017 - CALCiViS presents five new clinical publications at the 64th International Organisation for Caries Research (ORCA) meeting in Oslo, Norway.   The publications focus entirely on the revolutionary CALCiViS photoprotein and its unique ability to help determine early enamel demineralisation - at a stage when...

CALCiViS starts new FDA clinical study

Edinburgh, 09 January   2017 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that it has begun recruitment into a clinical study of approximately 100 patients assessing the performance of a commercial version of its CE marked CALCiViS imaging...

CALCiViS at Medtech Showcase 2017

Edinburgh, 10 January 2017 - CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces that Chief Executive Officer (CEO), Adam Christie, will present at the Medtech Showcase held at the 9th Annual Biotech Showcase™ today Tuesday, January 10th 2017 at...

CALCiViS at 2016 Organisation for Caries Research

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, presented new clinical and experimental data for the CALCiViS imaging system at the 63rd Congress of the European Organisation for Caries Research (ORCA) in Athens, Greece on 6-9 July 2016. CALCiViS presented...

CALCiViS wins place on London Stock Exchange’s ELITE Programme

Edinburgh, 26th April 2016 – CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces that it has been accepted into the next cohort of the London Stock Exchange (LSE)’s ELITE programme that supports ambitious companies towards growth and investment....

CALCiViS imaging system showcases at the 2016 Chicago Dental Society

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, showcases a prototype of its CALCiViS imaging system at the 151st Meeting of the Chicago Dental Society, held in Chicago, USA. The CALCiViS imaging system is the first device to allow dentists...

CALCiViS appoints Peter Rees as a Non-Executive Board Director

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces it has appointed Peter Rees as non-executive Board Director. Mr. Rees’s extensive experience of the dental market, in particular his demonstrated track record in sales and marketing and product launches,...

CALCiViS raises £4.5m for Development of the CALCIVIS imaging system

CALCiViS , a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, today announces it has secured £4.5m in new equity and grant funding. Existing funders, Archangel Investors and the Scottish Investment Bank, have invested a further £2.6m in the Company. CALCiViS has also...
Web Design by: Purple Imp